Performance of a Four-Antigen Staphylococcus aureus Vaccine in Preclinical Models of Invasive S. aureus Disease
Open Access
- 15 January 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (1), 177
- https://doi.org/10.3390/microorganisms9010177
Abstract
A Staphylococcus aureus four-antigen vaccine (SA4Ag) was designed for the prevention of invasive disease in surgical patients. The vaccine is composed of capsular polysaccharide type 5 and type 8 CRM197 conjugates, a clumping factor A mutant (Y338A-ClfA) and manganese transporter subunit C (MntC). S. aureus pathogenicity is characterized by an ability to rapidly adapt to the host environment during infection, which can progress from a local infection to sepsis and invasion of distant organs. To test the protective capacity of the SA4Ag vaccine against progressive disease stages of an invasive S. aureus infection, a deep tissue infection mouse model, a bacteremia mouse model, a pyelonephritis model, and a rat model of infectious endocarditis were utilized. SA4Ag vaccination significantly reduced the bacterial burden in deep tissue infection, in bacteremia, and in the pyelonephritis model. Complete prevention of infection was demonstrated in a clinically relevant endocarditis model. Unfortunately, these positive preclinical findings with SA4Ag did not prove the clinical utility of SA4Ag in the prevention of surgery-associated invasive S. aureus infection.Keywords
This publication has 43 references indexed in Scilit:
- Regulation of Staphylococcus aureus MntC Expression and Its Role in Response to Oxidative StressPLOS ONE, 2013
- A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus aureus That Are Not Observed after Natural ExposureClinical and Vaccine Immunology, 2012
- Staphylococcus aureus Manganese Transport Protein C Is a Highly Conserved Cell Surface Protein That Elicits Protective Immunity Against S. aureus and Staphylococcus epidermidisThe Journal of Infectious Diseases, 2012
- Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis modelHuman Vaccines & Immunotherapeutics, 2012
- Global Changes in Staphylococcus aureus Gene Expression in Human BloodPLOS ONE, 2011
- Preventing Surgical-Site Infections in Nasal Carriers ofStaphylococcus aureusThe New England Journal of Medicine, 2010
- Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian HospitalsAntimicrobial Agents and Chemotherapy, 2007
- Vaccine assembly from surface proteins ofStaphylococcus aureusProceedings of the National Academy of Sciences of the United States of America, 2006
- Identification of Staphylococcus aureus Proteins Recognized by the Antibody-Mediated Immune Response to a Biofilm InfectionInfection and Immunity, 2006
- A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis ModelInfection and Immunity, 2006